title: Histone deacetylase inhibitors: a new class of potential therapeutic agents for cancer treatment.
authors.affiliation: Aton Pharma, Inc., Tarrytown, New York 10591, USA. vrichon@atonpharma.com
authors.forename: Victoria M
authors.initials: VM
authors.lastname: Richon
authors.forename: James P
authors.initials: JP
authors.lastname: O'Brien
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D047630:Depsipeptides; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases / Q000737:chemistry; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010456:Peptides, Cyclic
chemical_list: D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D047630:Depsipeptides; D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors; D010456:Peptides, Cyclic; C087123:romidepsin; D006655:Histone Deacetylases